《滬深兩市》上證3,500點失而復得 深成創板全日跌0.4%-1.8% 醫械、醫藥、醫美股受壓
人行今日開展100億元人民幣(下同)7天期逆回購操作，今日有300億元逆回購到期；中標利率2.2%，持平上次。人民幣中間價上調82點。上證深成個別發展後曾雙雙向上，其後走勢轉弱，其中創業板較差。A股午後初段各指數跌幅一度擴大，上證試穿3,500點後有資金涌入，收市僅微跌。創業板跌幅一度擴大至逾3%，尾市跌幅顯着收窄。滬深兩市成交額連續第四個交易日突破萬億元。
上證低見3,496，全日微跌4點或0.1%，收報3,530點；深成跌51點或0.4%，收報14,667點；滬深300指數微跌2點，報5,083點；創業板指數跌60點或1.8%，收報3,291點，成交2,649億元。滬深兩市成交分別爲4,929億元及6,274億元。
中資金融股表現向好，工行(601398.SH)、建行(601939.SH)分別升0.4%、0.8%。
OPEC+暫停石油增產磋商，油價向好，中國石油(601857.SH)、中石化(600028.SH)分別升1.2%、0.5%。光伏股走低，中來股份(300393.SZ)、固德威(688390.SH)、拓日新能(002218.SZ)挫12.1%、4.5%、3.3%。
半導體、芯片股午後下挫，士蘭微(600460.SH)、中晶科技(003026.SZ)、景嘉微(300474.SZ)、樂鑫科技(688018.SH)、兆易創新(603986.SH )、華潤微(688396.SH)、晶澳科技(002459.SZ)、金辰股份(603396.SH)跌5.7%-7.8%。
醫藥、醫美、醫療器械股下跌，泰格醫藥(300347.SZ)、美迪西(688202.SH)各挫逾一成。復星醫藥(600196.SH)、愛爾眼科(300015.SZ)、康龍化成(300759.SZ)、藥明康德(603259.SH)跌5.1%-9.6%。中藥股片仔(黃)(600436.SH)、同仁堂(600085.SH)、信邦製藥(002390.SZ)跌2.3%-7.4%。奧園美谷(000615.SZ)跌停。金髮拉比(002762.SZ)、國際醫學(000516.SZ)、朗姿股份(002612.SZ)跌3.8%-5.9%。通策醫療(600763.SH)、拱東醫療(605369.SH)跌停。愛博醫療(688050.SH)急挫16.2%。
農業股逆市造好，敦煌種業(600354.SH)漲停，荃銀高科(300087.SZ)、登海種業(002041.SZ)、神農科技(300189.SZ)、大北農(002385.SZ)升4%-7.7%。
蘇寧易購(002024.SZ)復牌漲停，公司16.96%股權擬轉手，江蘇國資聯手阿裏小米入局，深國資退出；轉讓後公司將無實控人。公司預計上半年虧損25億元至32億元。
萬東醫療(600055.SH)曾漲停，全日升逾半成。公司擬定增募資不超過20.83億元，用於MRI產品、CT產品、DSA產品、DR及DRF產品等研發及產業化項目，控股股東美的集團將以現金方式全部認購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
